Forbes November 9, 2023
Arthur L. Kellermann

Concerns about the safety of over-the-counter eyedrops resurfaced last month when the FDA issued a warning to consumers to avoid using more than two dozen eyecare products due to bacterial contamination at their manufacturing plants. But this wasn’t a newly discovered risk.

The first news of a serious outbreak of eye infections caused by a highly drug-resistant strain of bacteria was reported by the CDC’s Health Alert Network on February 1, 2023. Laboratory testing determined that artificial tears were the source. Although the contaminated product was swiftly pulled from the market, the outbreak ultimately infected 81 people in 18 states. Fourteen lost their vision and four died.

The FDA responded by boosting inspections of overseas manufacturing plants, which had sharply...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Medical Devices, Pharma, Pharma / Biotech
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article